A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independently of age, transplant dose and granulocyte colony-stimulating factor support

Hematopoietic stem cell transplantation following myeloablative chemotherapy is a curative treatment for many hematopoietic malignancies. However, profound granulocytopenia during the interval between transplantation and marrow recovery exposes recipients to risks of fatal infection, a significant s...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Amar, Zhang, Yongyou, Park, Youngsoo, Dawson, Dawn M., Larusch, Gretchen A., Kasturi, Lakshmi, Wald, David, Ready, Joseph M., Gerson, Stanton L., Markowitz, Sanford D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058768/
https://www.ncbi.nlm.nih.gov/pubmed/29472361
http://dx.doi.org/10.3324/haematol.2017.178376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058768/
https://www.ncbi.nlm.nih.gov/pubmed/29472361
http://dx.doi.org/10.3324/haematol.2017.178376

Ejemplares similares